Phaseline

Targets › MIR-126

MIR-126: drug programs, companies and trials

1 program from 1 company in 1 trial: 1 Phase 1; Other.

Open in Phaseline: the race on MIR-126, likelihood bands and readouts

Programs

CompanyDrugTargetsHighest phaseConditionsNext expected readout
Universitas PadjadjaranMesenchymal Stem Cell-Derived Exosomes
Exosomes containing bioactive molecules (microRNAs including miR-126-3p, proteins, and lip
MIR-126Phase 1Preeclampsia–

Conditions

Preeclampsia (1)

Modalities

other (1)

Companies

Universitas Padjadjaran (1)

Related targets

–

Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.